About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
SMART QUOTES
Smart
Quotes
Ajanta Pharma Ltd.
Industry :
Pharmaceuticals & Drugs
BSE Code
532331
ISIN Demat
INE031B01049
Book Value
310.16
NSE Code
AJANTPHARM
Dividend Yield %
1.07
Market Cap
326562.98
P/E
34.90
EPS
74.91
Face Value
2
BSE
NSE
05-Sep-2025 12:53
BSE
NSE
NSE F & O
05-Sep-2025 12:44
BSE
NSE
NSE F & O
Last Price
2622.75
Net Change
21.5
% Change
0.83%
Prev.Close
2601.25
Open
2551.50
High
2625.40
Low
2551.50
Volume
2853
Last Price
2619.10
Net Change
18.4
% Change
0.71%
Prev.Close
2600.70
Open
2575.20
High
2627.50
Low
2566.20
Volume
36769
Value
7482705.75
Best Buy
2618.10
Best Sell
2623.60
Best Quantity
2
Sell Quantity
2
Today's Range
2625.40
52-Week High
3485.75
52-Week Low
2022.05
Value
96301687.9
Best Buy
2617.40
Best Sell
2619.10
Best Quantity
2
Sell Quantity
26
Today's Range
2627.50
52-Week High
3485.00
52-Week Low
2327.30
Open Price
High Price
Low Price
Last Price
Prev Close
Change
% Change
Average Price
Underlying Value
Number of contracts traded
Turnover in Rs. Lakhs
Open Interest
Change in O I
% Change in O I
%
Today
|
1W
|
1M
|
1Y
You need to upgrade your Flash Player
Best Bid
Best Offer
Quantity
2
Price
2618.10
Quantity
2
Price
2623.60
Best Bid
Best Offer
Quantity
2
Price
2617.40
Quantity
26
Price
2619.10
Best Bid
Best Offer
Quantity
Price
Quantity
Price
Holding Details
More
Latest Corporate Events
Bonus
1 : 2
22-Jun-22
Book Closure
23-Jul-20
30-Jul-20
Dividend
1400 %
06-Nov-24
Company News
02-09-2025
Ajanta Pharma informs ab...
29-07-2025
Ajanta Pharma informs abo...
18-07-2025
Ajanta Pharma informs abo...
08-07-2025
Ajanta Pharma informs abo...
19-06-2025
Ajanta Pharma informs abo...
17-06-2025
Ajanta Pharma informs ab...
12-05-2025
Ajanta Pharma informs abo...
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.
